DNA methylation markers in obesity, metabolic syndrome, and weight loss

M Samblas, FI Milagro, A Martínez - Epigenetics, 2019 - Taylor & Francis
The fact that not all individuals exposed to the same environmental risk factors develop
obesity supports the hypothesis of the existence of underlying genetic and epigenetic …

–Omic and electronic health record big data analytics for precision medicine

PY Wu, CW Cheng, CD Kaddi… - IEEE Transactions …, 2016 - ieeexplore.ieee.org
Objective: Rapid advances of high-throughput technologies and wide adoption of electronic
health records (EHRs) have led to fast accumulation of–omic and EHR data. These …

Analysing and interpreting DNA methylation data

C Bock - Nature Reviews Genetics, 2012 - nature.com
DNA methylation is an epigenetic mark that has suspected regulatory roles in a broad range
of biological processes and diseases. The technology is now available for studying DNA …

Spontaneous epigenetic variation in the Arabidopsis thaliana methylome

C Becker, J Hagmann, J Müller, D Koenig, O Stegle… - Nature, 2011 - nature.com
Heritable epigenetic polymorphisms, such as differential cytosine methylation, can underlie
phenotypic variation,. Moreover, wild strains of the plant Arabidopsis thaliana differ in many …

De novo identification of differentially methylated regions in the human genome

TJ Peters, MJ Buckley, AL Statham, R Pidsley… - Epigenetics & …, 2015 - Springer
Background The identification and characterisation of differentially methylated regions
(DMRs) between phenotypes in the human genome is of prime interest in epigenetics. We …

DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells

X Zhang, J Su, M Jeong, M Ko, Y Huang, HJ Park… - Nature …, 2016 - nature.com
Mutations in the epigenetic modifiers DNMT3A and TET2 non-randomly co-occur in
lymphoma and leukemia despite their epistasis in the methylation–hydroxymethylation …

Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases

C Schiano, G Benincasa, M Franzese… - Pharmacology & …, 2020 - Elsevier
The complex pathobiology underlying cardiovascular diseases (CVDs) has yet to be
explained. Aberrant epigenetic changes may result from alterations in enzymatic activities …

Genomic and epigenomic heterogeneity of hepatocellular carcinoma

DC Lin, A Mayakonda, HQ Dinh, P Huang, L Lin… - Cancer …, 2017 - aacrjournals.org
Understanding the intratumoral heterogeneity of hepatocellular carcinoma is instructive for
develo** personalized therapy and identifying molecular biomarkers. Here we applied …

Changes in correlation between promoter methylation and gene expression in cancer

M Moarii, V Boeva, JP Vert, F Reyal - BMC genomics, 2015 - Springer
Background Methylation of high-density CpG regions known as CpG Islands (CGIs) has
been widely described as a mechanism associated with gene expression regulation …

DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database

Y **ong, Y Wei, Y Gu, S Zhang, J Lyu… - Nucleic acids …, 2017 - academic.oup.com
The human disease methylation database (DiseaseMeth, http://bioinfo. hrbmu. edu.
cn/diseasemeth/) is an interactive database that aims to present the most complete …